v3.26.1
Net Loss per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Anti-dilutive securities                      
Net loss $ (57,939) $ (94,391)   $ (42,281) $ (73,238) $ (152,330) $ (115,519)        
Weighted average common shares outstanding (in shares) 23,072,084     22,207,017   23,015,961 22,149,492        
Pre-funded warrants (in shares) 3,605,790     3,605,790   3,605,790 3,605,790        
Weighted average earned PSUs (in shares) 97,600     50,000   97,600 34,254        
Basic weighted average number of shares outstanding (Note 13) (in shares) 29,145,271   28,508,089 28,232,604   29,089,148 28,159,333 28,276,865 28,409,706 26,908,070 21,562,581
Diluted weighted average number of shares outstanding (Note 13) (in shares) 29,145,271   28,508,089 28,232,604   29,089,148 28,159,333 28,276,865 28,409,706 26,908,070 21,562,581
Basic net loss per common, Series A preferred, and Series B preferred share (in dollars per share) $ (1.99)   $ (4.01) $ (1.50)   $ (5.24) $ (4.10) $ (8.12) $ (10.15) $ (17.31) $ (17.33)
Diluted net loss per common, Series A preferred, and Series B preferred share (in dollars per share) $ (1.99)   $ (4.01) $ (1.50)   $ (5.24) $ (4.10) $ (8.12) $ (10.15) $ (17.31) $ (17.33)
Series A preferred stock                      
Anti-dilutive securities                      
Incremental common shares attributable to dilutive effect of conversion of preferred stock (in shares) 1,969,797     1,969,797   1,969,797 1,969,797        
Series B preferred stock                      
Anti-dilutive securities                      
Incremental common shares attributable to dilutive effect of conversion of preferred stock (in shares) 400,000     400,000   400,000 400,000